MoU Or Statutory Fix? FDA/CMS “Harmonization” Strategies Are Under Review

FDA and CMS will likely produce a memorandum of understanding soon after the HHS Secretary's Advisory Panel on Regulatory Reform holds its final meeting Oct. 1-2 in Washington, D.C